TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 159 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,279,000 | +601.6% | 110,018 | +150.2% | 0.01% | +400.0% |
Q1 2022 | $1,180,000 | -86.6% | 43,976 | -76.1% | 0.00% | -50.0% |
Q4 2021 | $8,786,000 | +549.9% | 184,170 | +804.7% | 0.00% | +100.0% |
Q3 2021 | $1,352,000 | +148.5% | 20,358 | +192.4% | 0.00% | – |
Q2 2021 | $544,000 | -86.6% | 6,963 | -83.8% | 0.00% | -100.0% |
Q1 2021 | $4,056,000 | +142.7% | 42,888 | +212.5% | 0.00% | +100.0% |
Q4 2020 | $1,671,000 | +11.7% | 13,725 | -19.8% | 0.00% | 0.0% |
Q3 2020 | $1,496,000 | +8.1% | 17,119 | -20.1% | 0.00% | 0.0% |
Q2 2020 | $1,384,000 | +115.9% | 21,419 | +49.0% | 0.00% | 0.0% |
Q1 2020 | $641,000 | -63.6% | 14,379 | -49.2% | 0.00% | 0.0% |
Q4 2019 | $1,763,000 | +1075.3% | 28,295 | +608.8% | 0.00% | – |
Q3 2019 | $150,000 | -13.8% | 3,992 | -6.8% | 0.00% | – |
Q2 2019 | $174,000 | – | 4,281 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |